S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
NYSE:RE

Everest Re Group Stock Forecast, Price & News

$255.74
+0.52 (+0.20 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$253.27
$256.57
50-Day Range
$236.68
$273.68
52-Week Range
$193.02
$281.27
Volume145,890 shs
Average Volume283,086 shs
Market Capitalization$10.15 billion
P/E Ratio7.72
Dividend Yield2.43%
Beta0.65
30 days | 90 days | 365 days | Advanced Chart
Receive RE News and Ratings via Email

Sign-up to receive the latest news and ratings for Everest Re Group and its competitors with MarketBeat's FREE daily newsletter.


Everest Re Group logo

About Everest Re Group

Everest Re Group Ltd. is a holding company, which engages in the provision of reinsurance and insurance services. It operates through the following segments: U.S. Reinsurance, International, Bermuda, and Insurance. The U.S. Reinsurance segment writes property and casualty reinsurance and specialty lines of business, including marine, aviation, surety, and accident and health business, on both a treaty and facultative basis, through reinsurance brokers, as well as directly with ceding companies primarily within the U.S. The International segment offers foreign property and casualty reinsurance through Everest Re's branches in Canada and Singapore and through offices in Brazil, Miami, and New Jersey. The Bermuda segment comprises reinsurance and insurance to worldwide property and casualty markets through brokers and directly with ceding companies from its Bermuda office and reinsurance to the United Kingdom and European markets through its UK branch and Ireland Re. The Insurance segment writes property and casualty insurance directly and through brokers, surplus lines brokers, and general agents within the U.S., Canada, and Europe. The company was founded in 1999 and is headquartere

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.08 out of 5 stars

Finance Sector

589th out of 1,331 stocks

Fire, Marine, & Casualty Insurance Industry

37th out of 76 stocks

Analyst Opinion: 2.3Community Rank: 3.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Everest Re Group (NYSE:RE) Frequently Asked Questions

Is Everest Re Group a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Everest Re Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Everest Re Group stock.
View analyst ratings for Everest Re Group
or view top-rated stocks.

What stocks does MarketBeat like better than Everest Re Group?

Wall Street analysts have given Everest Re Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Everest Re Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Everest Re Group's next earnings date?

Everest Re Group is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Everest Re Group
.

How can I listen to Everest Re Group's earnings call?

Everest Re Group will be holding an earnings conference call on Thursday, October 28th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Everest Re Group's earnings last quarter?

Everest Re Group, Ltd. (NYSE:RE) released its quarterly earnings results on Wednesday, July, 28th. The insurance provider reported $14.63 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $7.30 by $7.33. The insurance provider had revenue of $2.97 billion for the quarter. Everest Re Group had a trailing twelve-month return on equity of 9.13% and a net margin of 11.87%. During the same period in the previous year, the firm posted $2.07 EPS.
View Everest Re Group's earnings history
.

How has Everest Re Group's stock price been impacted by Coronavirus (COVID-19)?

Everest Re Group's stock was trading at $227.95 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RE shares have increased by 12.2% and is now trading at $255.74.
View which stocks have been most impacted by COVID-19
.

How often does Everest Re Group pay dividends? What is the dividend yield for Everest Re Group?

Everest Re Group declared a quarterly dividend on Wednesday, August 11th. Investors of record on Wednesday, August 25th will be paid a dividend of $1.55 per share on Wednesday, September 15th. This represents a $6.20 annualized dividend and a dividend yield of 2.42%. The ex-dividend date of this dividend is Tuesday, August 24th.
View Everest Re Group's dividend history
.

Is Everest Re Group a good dividend stock?

Everest Re Group pays an annual dividend of $6.20 per share and currently has a dividend yield of 2.43%. Everest Re Group does not yet have a strong track record of dividend growth. The dividend payout ratio of Everest Re Group is 83.11%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, Everest Re Group will have a dividend payout ratio of 18.93% next year. This indicates that Everest Re Group will be able to sustain or increase its dividend.
View Everest Re Group's dividend history.

What price target have analysts set for RE?

6 equities research analysts have issued twelve-month price objectives for Everest Re Group's stock. Their forecasts range from $235.00 to $330.00. On average, they anticipate Everest Re Group's share price to reach $290.67 in the next year. This suggests a possible upside of 13.7% from the stock's current price.
View analysts' price targets for Everest Re Group
or view top-rated stocks among Wall Street analysts.

Who are Everest Re Group's key executives?

Everest Re Group's management team includes the following people:
  • Juan C. Andrade, President, Chief Executive Officer & Director
  • Jim Williamson, Chief Operating Officer & Executive Vice President
  • Mark Kociancic, Chief Financial Officer & Executive Vice President
  • Sanjoy Mukherjee, Secretary, Chief Compliance Officer & Executive VP
  • Ronald D. Diaz, Executive Vice President & Head-International

What is Juan Andrade's approval rating as Everest Re Group's CEO?

1 employees have rated Everest Re Group CEO Juan Andrade on Glassdoor.com. Juan Andrade has an approval rating of 100% among Everest Re Group's employees. This puts Juan Andrade in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Everest Re Group's key competitors?

What other stocks do shareholders of Everest Re Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Everest Re Group investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AbbVie (ABBV), UnitedHealth Group (UNH), Exxon Mobil (XOM), Bank of America (BAC), iShares Nasdaq Biotechnology ETF (IBB), Northrop Grumman (NOC), Phillips 66 (PSX) and Adobe (ADBE).

What is Everest Re Group's stock symbol?

Everest Re Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "RE."

Who are Everest Re Group's major shareholders?

Everest Re Group's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.09%), BlackRock Inc. (5.66%), Boston Partners (5.97%), State Street Corp (4.77%), Franklin Resources Inc. (4.48%) and Capital International Investors (4.04%). Company insiders that own Everest Re Group stock include Geraldine Losquadro, John P Doucette, Joseph V Taranto and William F Galtney Jr.
View institutional ownership trends for Everest Re Group
.

Which institutional investors are selling Everest Re Group stock?

RE stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Capital International Investors, Nuveen Asset Management LLC, Swiss National Bank, APG Asset Management N.V., Cary Street Partners Asset Management LLC, Scout Investments Inc., and Boston Partners.
View insider buying and selling activity for Everest Re Group
or view top insider-selling stocks.

Which institutional investors are buying Everest Re Group stock?

RE stock was bought by a variety of institutional investors in the last quarter, including Los Angeles Capital Management LLC, Franklin Resources Inc., Prana Capital Management LP, Schonfeld Strategic Advisors LLC, Nuance Investments LLC, Victory Capital Management Inc., Balyasny Asset Management LLC, and AQR Capital Management LLC.
View insider buying and selling activity for Everest Re Group
or or view top insider-buying stocks.

How do I buy shares of Everest Re Group?

Shares of RE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Everest Re Group's stock price today?

One share of RE stock can currently be purchased for approximately $255.74.

How much money does Everest Re Group make?

Everest Re Group has a market capitalization of $10.15 billion and generates $9.60 billion in revenue each year. The insurance provider earns $514.15 million in net income (profit) each year or $7.46 on an earnings per share basis.

How many employees does Everest Re Group have?

Everest Re Group employs 1,746 workers across the globe.

When was Everest Re Group founded?

Everest Re Group was founded in 1973.

What is Everest Re Group's official website?

The official website for Everest Re Group is www.everestre.com.

Where are Everest Re Group's headquarters?

Everest Re Group is headquartered at 141 Front Street, HAMILTON D0, HM 19.

How can I contact Everest Re Group?

Everest Re Group's mailing address is 141 Front Street, HAMILTON D0, HM 19. The insurance provider can be reached via phone at (441) 295-0006 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.